Real-World Patient Awareness Around Emerging Gene Therapies: Implications for Barriers to Access

by alfie | Dec 12, 2024 | study and resources

SICKLE CELL DISEASE Patient experience, treatment adherence and unmet need in UK CML community British Society For Haematology (BSH) Annual Scientific Meeting (2024) Areas of interest /Real-world awareness for Novel Therapeutic Target /Awareness, Knowledge, Interests,...

Patient experience, treatment adherence and unmet need in UK CML community

by alfie | Dec 12, 2024 | study and resources

CHRONIC MYELOID LEUKAEMIA Patient experience, treatment adherence and unmet need in UK CML community British Society For Haematology (BSH) Annual Scientific Meeting (2024) Areas of interest /Real-world experience & unmet needs Target /Treatment, Healthcare...

A Real-World Patient Experiences and Quality of Life Insights Snapshot in Cold Agglutinin Disease (CAD)

by alfie | Dec 12, 2024 | study and resources

COLD AGGLUTININ DISEASE A Real-World Patient Experiences and Quality of Life Insights Snapshot in Cold Agglutinin Disease (CAD) British Society For Haematology (BSH) Annual Scientific Meeting (2024) Areas of interest /Real-world experience & unmet needs Biomarkers...

Evaluation of a smartphone app (My CML) to support patients with Chronic Myeloid Leukaemia: the patient perspective

by alfie | Dec 12, 2024 | study and resources

CHRONIC MYELOID LEUKAEMIA Evaluation of a smartphone app (My CML) to support patients with Chronic Myeloid Leukaemia: the patient perspective British Oncology Pharmacy Association (BOPA) Annual Meeting October 2024 Areas of interest /Digital Healthcare Solution...

Mapping the Prodromal Stage of Vaso-occlusive Crises: A Patient Experience and Wearable Biometrics-driven Approach

by alfie | Dec 12, 2024 | study and resources

SICKLE CELL DISEASE Mapping the Prodromal Stage of Vaso-occlusive Crises: A Patient Experience and Wearable Biometrics-driven Approach 29th European Hematology Association Congress (2024) Areas of interest /Longitudinal digital outcomes & biometrics tracking...

Monitoring the Real World Impacts of Voxelotor Treatment on Blood Transfusion Requirements, Quality of Life, And Physiological wearable metrics in UK patients with sickle cell disease

by alfie | Dec 12, 2024 | study and resources

WALDENSTROM MACROGLOBULINEMIA Wearable Technology and Subjective Health Outcomes in Waldenstrom macroglobulinemia: A Remote Longitudinal approach to Active Monitoring 29th European Hematology Association Congress (2024) Areas of interest /Longitudinal digital outcomes...